# Influenzinum

NDC: 0220-5181
Generic name: INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Labeler / Manufacturer: Boiron
Product type: HUMAN OTC DRUG
Marketing category: UNAPPROVED HOMEOPATHIC
Dosage form: PELLET
Routes: ORAL
Marketing started: 20260914



## Active ingredients

- INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [hp_X]/8[hp_X]
- INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [hp_X]/8[hp_X]
- INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [hp_X]/8[hp_X]

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0220-5181"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0220-5181